Mesenchymal Stem/stromal Cells in Cancer Therapy

Overview

Journal J Hematol Oncol

Publisher Biomed Central

Specialties Hematology
Oncology

Date 2021 Nov 18

PMID 34789315

Citations 102

Authors

Tianxia Lan

Min Luo

Xiawei Wei

Affiliations

Soon will be listed here.

Abstract

The multipotent mesenchymal stem/stromal cells (MSCs), initially discovered from bone marrow in 1976, have been identified in nearly all tissues of human body now. The multipotency of MSCs allows them to give rise to osteocytes, chondrocytes, adipocytes, and other lineages. Moreover, armed with the immunomodulation capacity and tumor-homing property, MSCs are of special relevance for cell-based therapies in the treatment of cancer. However, hampered by lack of knowledge about the controversial roles that MSC plays in the crosstalk with tumors, limited progress has been made with regard to translational medicine. Therefore, in this review, we discuss the prospects of MSC-associated anticancer strategies in light of therapeutic mechanisms and signal transduction pathways. In addition, the clinical trials designed to appraise the efficacy and safety of MSC-based anticancer therapies will be assessed according to published data.

Citing Articles

Nicotinamide adenine dinucleotide rejuvenates septic bone marrow mesenchymal stem cells.

Xia X, Zhou K, An L, Zhao M, Tian B, Zhao J World J Stem Cells. 2025; 17(2):96893.

PMID: 40061269 PMC: 11885940. DOI: 10.4252/wjsc.v17.i2.96893.

Progress of mesenchymal stem cells affecting extracellular matrix metabolism in the treatment of female stress urinary incontinence.

Fang C, Zeng Z, Ye J, Ni B, Zou J, Zhang G Stem Cell Res Ther. 2025; 16(1):95.

PMID: 40001265 PMC: 11863768. DOI: 10.1186/s13287-025-04220-w.

Apoptotic mesenchymal stem cells and their secreted apoptotic extracellular vesicles: therapeutic applications and mechanisms.

Wang R, Fu J, He J, Wang X, Xing W, Liu X Stem Cell Res Ther. 2025; 16(1):78.

PMID: 39985021 PMC: 11846181. DOI: 10.1186/s13287-025-04211-x.

Mesenchymal Stromal Cell-Based Therapy: A Promising Approach for Autoimmune Diseases.

Li L, He Y, Zhao J, Yin H, Feng X, Fan X Clin Rev Allergy Immunol. 2025; 68(1):21.

PMID: 39982546 DOI: 10.1007/s12016-025-09030-9.

Extracellular Vesicles as Mediators and Potential Targets in Combating Cancer Drug Resistance.

Zhang H, Wu B, Wang Y, Du H, Fang L Molecules. 2025; 30(3).

PMID: 39942602 PMC: 11819960. DOI: 10.3390/molecules30030498.

References

Levental K, Yu H, Kass L, Lakins J, Egeblad M, Erler J . Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009; 139(5):891-906. PMC: 2788004. DOI: 10.1016/j.cell.2009.10.027. View

Russell J, Monga S . Wnt/β-Catenin Signaling in Liver Development, Homeostasis, and Pathobiology. Annu Rev Pathol. 2017; 13:351-378. PMC: 5927358. DOI: 10.1146/annurev-pathol-020117-044010. View

Stoff-Khalili M, Rivera A, Mathis J, Sanjib Banerjee N, Moon A, Hess A . Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma. Breast Cancer Res Treat. 2007; 105(2):157-67. DOI: 10.1007/s10549-006-9449-8. View

Zhang T, Lee Y, Rui Y, Cheng T, Jiang X, Li G . Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors. Stem Cell Res Ther. 2013; 4(3):70. PMC: 3707041. DOI: 10.1186/scrt221. View

Wang X, Su X, Cheng S, Sun Z, Huang Z, Ou T . MYC modulators in cancer: a patent review. Expert Opin Ther Pat. 2019; 29(5):353-367. DOI: 10.1080/13543776.2019.1612878. View

Naji A, Eitoku M, Favier B, Deschaseaux F, Rouas-Freiss N, Suganuma N . Biological functions of mesenchymal stem cells and clinical implications. Cell Mol Life Sci. 2019; 76(17):3323-3348. PMC: 11105258. DOI: 10.1007/s00018-019-03125-1. View

Zhang C, Huang T, Wu B, He W, Liu D . Stem cells in cancer therapy: opportunities and challenges. Oncotarget. 2017; 8(43):75756-75766. PMC: 5650462. DOI: 10.18632/oncotarget.20798. View

Houghton J, Stoicov C, Nomura S, Rogers A, Carlson J, Li H . Gastric cancer originating from bone marrow-derived cells. Science. 2004; 306(5701):1568-71. DOI: 10.1126/science.1099513. View

Zhou W, Zhou Y, Chen X, Ning T, Chen H, Guo Q . Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment. Biomaterials. 2020; 268:120546. DOI: 10.1016/j.biomaterials.2020.120546. View

10.

Yong R, Shinojima N, Fueyo J, Gumin J, Vecil G, Marini F . Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas. Cancer Res. 2009; 69(23):8932-40. PMC: 2789204. DOI: 10.1158/0008-5472.CAN-08-3873. View

11.

Tondreau T, Meuleman N, Delforge A, Dejeneffe M, Leroy R, Massy M . Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells. 2005; 23(8):1105-12. DOI: 10.1634/stemcells.2004-0330. View

12.

Seo S, Kim K, Park S, Suh Y, Kim S, Jeun S . The effects of mesenchymal stem cells injected via different routes on modified IL-12-mediated antitumor activity. Gene Ther. 2011; 18(5):488-95. PMC: 3125103. DOI: 10.1038/gt.2010.170. View

13.

Greten F, Eckmann L, Greten T, Park J, Li Z, Egan L . IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell. 2004; 118(3):285-96. DOI: 10.1016/j.cell.2004.07.013. View

14.

Lv F, Tuan R, Cheung K, Leung V . Concise review: the surface markers and identity of human mesenchymal stem cells. Stem Cells. 2014; 32(6):1408-19. DOI: 10.1002/stem.1681. View

15.

Bouchekioua A, Scourzic L, De Wever O, Zhang Y, Cervera P, Aline-Fardin A . JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma. Leukemia. 2013; 28(2):338-48. DOI: 10.1038/leu.2013.157. View

16.

Loebinger M, Eddaoudi A, Davies D, Janes S . Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer. Cancer Res. 2009; 69(10):4134-42. PMC: 2699841. DOI: 10.1158/0008-5472.CAN-08-4698. View

17.

Bajetto A, Pattarozzi A, Corsaro A, Barbieri F, Daga A, Bosio A . Different Effects of Human Umbilical Cord Mesenchymal Stem Cells on Glioblastoma Stem Cells by Direct Cell Interaction or Via Released Soluble Factors. Front Cell Neurosci. 2017; 11:312. PMC: 5645520. DOI: 10.3389/fncel.2017.00312. View

18.

Khakoo A, Pati S, Anderson S, Reid W, Elshal M, Rovira I . Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med. 2006; 203(5):1235-47. PMC: 2121206. DOI: 10.1084/jem.20051921. View

19.

Audsley K, Wagner T, Ta C, Newnes H, Buzzai A, Barnes S . IFNβ Is a Potent Adjuvant for Cancer Vaccination Strategies. Front Immunol. 2021; 12:735133. PMC: 8450325. DOI: 10.3389/fimmu.2021.735133. View

20.

Pidelaserra-Marti G, Engeland C . Mechanisms of measles virus oncolytic immunotherapy. Cytokine Growth Factor Rev. 2020; 56:28-38. DOI: 10.1016/j.cytogfr.2020.07.009. View